Screening for the Hypoglycaemic Potentials of the Extract of Vernonia amyggalina

This work evaluates the hypoglycemic effect of Vernonia amygdalina on alloxan induced diabetic rats. Different doses of the aqueous leaf extract of Vernonia amygdalina (50mg/kg, 100mg/kg, 200mg/kg and 400mg/kg) were administered to alloxan induced diabetic rats under experimental conditions. The mean fasting blood sugar levels of the groups of diabetic rats increased significantly as it rose from basal blood sugar levels (mg/dl) of 38.0, 39.2, 35.2 and 35.8 to fasting blood sugar levels (mg/dl) of 277.6, 284.8, 256.4 and 265.6. The findings showed that there is a dose dependent reduction in fasting blood sugar in alloxan induced diabetic rats after treatment to 167.5mg/dl, 140.8mg/dl, 104.2mg/dl and 80.4mg/ dl respectively

Foliar Epidermal Morphology and Anti-diabetic Property of Andrographis paniculata (Burm. f.) Wall ex. Nees

The leaf epidermal features and anti diabetic property of Androgragphis paniculata were investigated. The epidermal cells are polygonal to irregular with curved to undulate anticlinal walls on both surfaces of the leaf. The leaf is hypostomatic with stomata restricted to the abaxial surface. Stomata type is axillocytic. The epidermal cells contain deposits of crystal oxalates while cystoliths are found in a few cells. The leaf extract was evaluated for hypoglycemic effects. There was significant hypoglycemic effect in alloxan induced diabetic rats following administration of the leaf aqueous extract. The result shows that the level of fasting blood sugar was dependent on the previous level of basal blood sugar in the four groups of rats used for this study. Treatment of the rats with A. paniculata showed a dose dependent relationship with the time it took for the blood of the rats to return to the basal blood sugar levels. The study supports the use of the plant in the management and treatment of diabetes

Custo de implantação dos sistemas intensivos de criação de suínos confinado e ao ar livre.

bitstream/item/85041/1/DCOT-207.pd

Radiation Recall Pneumonitis Anticipates Bilateral Immune-Induced Pneumonitis in Non-Small Cell Lung Cancer

Radiation recall pneumonitis (RRP) is a rare inflammatory reaction that occurs in previously irradiated fields, and it may be caused by various triggering agents. Immunotherapy has been reported to potentially be one of these triggers. However, precise mechanisms and specific treatments have not been explored yet due to a lack of data in this setting. Here, we report a case of a patient who received radiation therapy and immune checkpoint inhibitor therapy for non-small cell lung cancer. He developed first radiation recall pneumonitis and subsequently immune-checkpoint inhibitor-induced pneumonitis (IIP). After presenting the case, we discuss the currently available literature on RRP and the challenges of differential diagnosis between RRP, IIP, and other forms of pneumonitis. We believe that this case is of particular clinical value since it highlights the importance of including RRP in a differential diagnosis of lung consolidation during immunotherapy. Furthermore, it suggests that RRP might anticipate more extensive ICI-induced pneumonitis

Pharmacogenomics: A Step forward Precision Medicine in Childhood Asthma

Personalized medicine, an approach to care in which individual characteristics are used for targeting interventions and maximizing health outcomes, is rapidly becoming a reality for many diseases. Childhood asthma is a heterogeneous disease and many children have uncontrolled symptoms. Therefore, an individualized approach is needed for improving asthma outcomes in children. The rapidly evolving fields of genomics and pharmacogenomics may provide a way to achieve asthma control and reduce future risks in children with asthma. In particular, pharmacogenomics can provide tools for identifying novel molecular mechanisms and biomarkers to guide treatment. Emergent high-throughput technologies, along with patient pheno-endotypization, will increase our knowledge of several molecular mechanisms involved in asthma pathophysiology and contribute to selecting and stratifying appropriate treatment for each patient

ETHNOBOTANICAL SURVEY AND PHYTOCHEMICAL ANALYSIS OF MEDICINAL PLANTS USED IN SOUTHWESTERN PART OF NIGERIA AS ANALGESICS

The gradual threat to plants and the inevitable disappearance of the aged Traditional Medical Practitioner are posing an impending time limit for people to learn, acquire, and document the rich medical cultural endowment.  This cultural endowment is essential for the benefit of all Africans and indeed the entire mankind. Hence, the urgent need for continual ethno-botanical survey of medicinal plants in Nigeria. Ethnobotanical survey was carried out using structured questionnaire to obtain information from trado-medical practitioners from Ogun, Oyo, Ondo and Lagos States.  Samples of eleven commonly used plants were collected and authenticated at the Forest Herbarium Ibadan, where voucher specimens were deposited. Extracts of each plant (leaf, root or seeds) were obtained by soxhlet extraction using methanol, diethyl ether and water, concentrated and screened for phytochemical constituents using standard procedures. Thirty-one plant species belonging to 24 families are being used as analgesics, of which Macrosphyra longistyla, Strophanthus hispidus, Buchholzia coriacea, Calliandra portoricensis, Secamone afzeli, Chasmanthera dependens, Spilanthes filicaulis, Moringa oleifera, Clerodendrum volubile, Petiveria alliacea, Carpolobia lutea were prevalent. Methanol and diethyl ether extracts of the plants contained alkaloids, saponins, tannins, phenols, anthraquinones and glycosides while, aqueous extracts contained alkaloids, saponins and glycosides. &nbsp

Dive performance in a small-bodied, semi-aquatic mammal in the wild

Aquatic foraging is a fundamental component of the behavior of a number of small mammals, yet comprehensive observations of diving are often difficult to obtain under natural circumstances. Semiaquatic mammals, having evolved to exploit prey in both aquatic and terrestrial environments, are generally not as well adapted for diving (or for life in the water) as are fully aquatic species. Because dive ability also tends to increase with body size, small, semiaquatic mammals are presumed to have fairly limited dive ability. Nevertheless, diving plays an important role in food acquisition for many such species. We used time–depth recorders (TDRs) to measure and describe the dive performance of 9 female and 5 male free-living American mink (Neovison vison; body mass approximately 1 kg) on lowland rivers in the southern United Kingdom. We recorded dives up to 2.96 m deep (maximum depth X ¯ 5 1.82 m) and up to 57.9 s in duration (maximum duration X ¯ 5 37.2 s). Dive duration was approximately 40% of that predicted by allometry for all air-breathing diving vertebrates (as might be expected for a small, semiaquatic animal) but was twice as long as previously measured for mink in captivity. Mink performed up to 189 dives per day (X ¯ 5 35.7 dives/day), mostly during daylight, and spent a maximum of 38.4 minutes diving per day (X ¯ 5 7.6 min/day). Some individuals maintained particularly high diving rates over the coldest months, suggesting that the benefits of aquatic foraging in winter outweigh the costs of heat loss. We observed a number of very shallow dives (depth approximately 0.3 m) of particularly long duration (up to 30 s). The function of these dives is currently unknown, but possibilities include searching for prey, travelling, or avoidance of threats. There is only 1 other study of which we are aware that presents detailed measurements of dive performance in a small, shallow-diving, semiaquatic mammal.Fil: Harrington, Lauren. University of Oxford; Reino UnidoFil: Hays, Graeme C.. Swansea University; Reino UnidoFil: Fasola, Laura. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Austral de Investigaciones Científicas; ArgentinaFil: Harrington, Andrew L.. University of Oxford; Reino UnidoFil: Righton, David. No especifíca;Fil: Macdonald, David W.. University of Oxford; Reino Unid

Complexity of biogeographic pattern in the endangered crayfish Austropotamobius italicus in northern Italy: molecular insights of conservation concern.

The protection of freshwater biodiversity has become a priority task for conservation practices, as freshwater ecosystems host high levels of cryptic diversity, while also record similarly high rates of extinction. The Italian white-clawed crayfish Austropotamobius italicus is an endemic freshwater crustacean, threatened by several anthropogenic impacts such as habitat fragmentation, pol- lution, invasion of exotics, and climate change. Previous phylogenetic studies conducted in Italy pointed out a complex phylogeographic framework for the species, with four different subspecies currently recognized. Conserva- tion efforts, particularly when involving restocking and reintroduction, require a detailed knowledge of their pop- ulation genetics. In this study we describe the genetic structure of A. italicus populations in northern Italy (Lombardy Alpine foothills and northern Apennines) by using the informative mitochondrial marker cytochrome c oxidase subunit I, in order to assess their current evolu- tionary diversity and past phylogeographic history from a conservation perspective. Our results contribute to the mapping of the contact area among A. i. carsicus and A. i. carinthiacus in the Orobie Larian Prealps. Moreinterestingly, we highlight the existence of two deeply differentiated evolutionary lineages within A. i. carsicus, showing alternative phylogeographic patterns and past demographic trends. We propose to consider these two clades as distinct molecular operational taxonomic units for the conservation of this endangered crayfish

What to do in an oncology department to face the new COVID-19 era challenges?

9noItaly was the first European country to be hit by COVID-19 pandemic. As a consequence, Italian oncologists had to guarantee essential treatments although minimizing exposure to the virus, and accidental infection, of patients and healthcare professionals. As Department of Medical Oncology of the University Hospital of Udine, in this short report, we describe the measures that we have taken, and gradually updated, since February 26, 2020. All accesses to our Oncology facilities are currently regulated by entrance check-points where patients are screened for infections following dedicated algorithms. Up to date, after 6 weeks of systematic execution of swabs no physician, nurse or other individual of the staff has been found positive to COVID-19. Only one patient admitted for therapy has been identified as COVID-19 positive. The aim of our work is to propose a model, made up of a set of operative procedures, that may be adopted by all the oncologists that daily struggle to guarantee safety and care in Oncology during this COVID-19 emergency.openopenGarattini S.K.; Bin A.; Donato R.; Mansutti M.; Rizzato S.; Troiero G.; Candoni A.; Fanin R.; Fasola G.Garattini, S. K.; Bin, A.; Donato, R.; Mansutti, M.; Rizzato, S.; Troiero, G.; Candoni, A.; Fanin, R.; Fasola, G

Rare and Insidious Toxicities from New Combination Therapies in Metastatic Renal Cell Cancer: Lessons Learned from Real-Practice

The advent of immune checkpoint inhibitors in combination with multitarget tyrosine kinase inhibitors has become a standard first-line treatment for metastatic renal cell cancer. Along with survival improvement, new toxicities have emerged. Such adverse events are still complex to be managed and some of them are rare and could be insidious or even fatal. Medical oncologists dispose of guidelines about the management of toxicities from immune checkpoint inhibitors but not for combinations. Therefore, it is still difficult to properly attribute and manage additive or overlapping adverse events. We report two clinical cases regarding rare treatment-related endocrine toxicities—hypophysitis and thyroiditis—with particular focus on their management. To this purpose, immune checkpoint-related toxicities guidelines represent the starting point. However, their implementation with additional measures is needed, considering the increasing complexity of current clinical scenarios. The goal is to correctly recognize adverse events and address side effects, so as not to discontinue effective treatments. We, therefore, aim at discussing the points of proper management of toxicities and individuating potential areas of improvement